Hegmans, J.P.J.J.

mesothelioma protein tumor patient cancer exosome factor effusion study antigen antibody prognostic analysis dendritic survival phage expression tumour response dendritic cells treatment figure immunotherapy fluid prognostic factors serum sample system selection growth proteomic diagnosis asbestos membrane chapter model immunol level cytokine marker fluorescein-dhpe tissue tumor cells group disease result effect therapy number mesothelioma cell lines value function fraction presence peptide subtype netherland table chemotherapy carcinoma prognostic factor stage fragment apo ci condition prognosis t cells hegman lysate t-cell method control library weight oncol trial 2005. pmr-mm 7 cells pathol surface